HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
About this episode
Experts discuss recent data and management strategies for HER2-positive gastrointestinal cancers.
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management. CME information and select publications here .
People in this episode
Host: Dr Lionel A Kankeu Fonkoua
Guests: Dr Haley Ellis, Prof Eric Van Cutsem, Dr Zev Wainberg
Mentioned in this episode
Organizations: Harvard Medical School, University Hospitals Leuven, UCLA School of Medicine, Mayo Clinic
More episodes of Gastrointestinal Cancer Update
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Localized Colorectal Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Localized Colorectal Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Explore listener stats, chart rankings, contacts and more on the Gastrointestinal Cancer Update podcast page.